ATE437234T1 - Verfahren zur herstellung eines physiologisch aktiven il-18 polypeptids - Google Patents

Verfahren zur herstellung eines physiologisch aktiven il-18 polypeptids

Info

Publication number
ATE437234T1
ATE437234T1 AT01958830T AT01958830T ATE437234T1 AT E437234 T1 ATE437234 T1 AT E437234T1 AT 01958830 T AT01958830 T AT 01958830T AT 01958830 T AT01958830 T AT 01958830T AT E437234 T1 ATE437234 T1 AT E437234T1
Authority
AT
Austria
Prior art keywords
polypeptide
producing
physiologically active
physiologically
active
Prior art date
Application number
AT01958830T
Other languages
English (en)
Inventor
Kyung Johanson
Robert Kirkpatrick
Allan Shatzman
Yen Ho
Patrick Mcdevitt
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE437234T1 publication Critical patent/ATE437234T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Engineering & Computer Science (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT01958830T 2000-06-15 2001-06-11 Verfahren zur herstellung eines physiologisch aktiven il-18 polypeptids ATE437234T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US21183200P 2000-06-15 2000-06-15
US22412800P 2000-08-10 2000-08-10
US26492301P 2001-01-20 2001-01-20
PCT/US2001/018804 WO2001098455A2 (en) 2000-06-15 2001-06-11 Method for preparing a physiologically active il-18 polypeptide

Publications (1)

Publication Number Publication Date
ATE437234T1 true ATE437234T1 (de) 2009-08-15

Family

ID=27395664

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01958830T ATE437234T1 (de) 2000-06-15 2001-06-11 Verfahren zur herstellung eines physiologisch aktiven il-18 polypeptids

Country Status (24)

Country Link
US (2) US7186528B2 (de)
EP (1) EP1292697B1 (de)
JP (1) JP5121109B2 (de)
KR (1) KR20030022144A (de)
CN (1) CN100390281C (de)
AR (1) AR033979A1 (de)
AT (1) ATE437234T1 (de)
AU (2) AU8044201A (de)
BR (1) BR0111692A (de)
CA (1) CA2412730C (de)
CZ (1) CZ20024085A3 (de)
DE (1) DE60139316D1 (de)
DK (1) DK1292697T3 (de)
ES (1) ES2329875T3 (de)
HU (1) HUP0501002A3 (de)
IL (2) IL153422A0 (de)
MX (1) MXPA02012292A (de)
MY (1) MY136526A (de)
NO (1) NO330682B1 (de)
NZ (1) NZ522845A (de)
PL (2) PL366134A1 (de)
PT (1) PT1292697E (de)
SI (1) SI1292697T1 (de)
WO (1) WO2001098455A2 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2399148A1 (en) * 2000-02-10 2001-08-16 Abbott Laboratories Antibodies that bind human interleukin-18 and methods of making and using
EP2261244A3 (de) 2003-04-15 2011-02-23 Glaxosmithkline LLC Humane IL-18 Substitutionsmutanten und deren Konjugate
EP2426140A1 (de) 2003-08-15 2012-03-07 University of Florida Research Foundation, Inc. Identifizierung von Porphyromonas Gingivalis Virulenz-Polynukleotiden bei der Diagnose, Behandlung und Überwachung von Periodontalerkrankungen
US7968684B2 (en) 2003-11-12 2011-06-28 Abbott Laboratories IL-18 binding proteins
CA2545024A1 (en) * 2003-11-24 2005-06-02 Novo Nordisk A/S Fusion proteins and methods of cleavage of such proteins
AU2005277404A1 (en) * 2004-08-20 2006-03-02 Smithkline Beecham Corporation Methods of healing wounds by administering human IL-18
EP2059253A4 (de) 2006-09-14 2011-09-14 Univ Pennsylvania Modulation regulatorischer t-zellen mittels human-il-18
PE20090190A1 (es) 2007-03-23 2009-03-22 Smithkline Beecham Corp Combinacion de anticuerpos anti-cd20 y polipeptidos de il-18
KR101940430B1 (ko) 2014-08-07 2019-01-18 가꼬우호우징 효고 이카다이가쿠 Il-18과 분자 표적 항체를 병용하는 암 치료약
JP2019023165A (ja) * 2015-12-11 2019-02-14 国立大学法人京都大学 インターロイキン−１８活性阻害剤
IL272635B2 (en) 2017-09-06 2024-02-01 Univ Yale Variants of interleukin-18 and methods of use
KR20200080749A (ko) * 2018-12-27 2020-07-07 주식회사 폴루스 N-말단의 메티오닌이 절단된 목적 단백질 발현용 유전자 발현 카세트 및 이를 이용하여 n-말단의 메티오닌이 절단된 목적 단백질을 생산하는 방법
AU2023226512A1 (en) 2022-02-23 2024-08-29 Bright Peak Therapeutics Ag Immune antigen specific il-18 immunocytokines and uses thereof

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985863A (en) * 1996-09-12 1999-11-16 Vertex Pharmaceuticals, Inc. Compositions and methods for decreasing IGIF and IFN-γ production by administering an ICE inhibitor
US6204261B1 (en) * 1995-12-20 2001-03-20 Vertex Pharmaceuticals Incorporated Inhibitors of interleukin-1β Converting enzyme inhibitors
US5192324A (en) 1982-02-18 1993-03-09 Howmedica Inc. Bone prosthesis with porous coating
ATE247708T1 (de) * 1986-10-02 2003-09-15 Massachusetts Inst Technology Verfahren zur regulierung der metabolischen stabilität von proteinen
US5212058A (en) 1990-05-09 1993-05-18 Massachusetts Institute Of Technology Nucleic acid encoding ubiquitin-specific proteases
JP3041644B2 (ja) 1990-05-09 2000-05-15 マサチューセッツ インスティチュート オブ テクノロジー ユビキチン特異的プロテアーゼ
US5914254A (en) * 1993-08-02 1999-06-22 Celtrix Pharmaceuticals, Inc. Expression of fusion polypeptides transported out of the cytoplasm without leader sequences
US5552536A (en) 1994-04-08 1996-09-03 Merck Frosst Canada, Inc. DNA encoding precursor of interleukin-1 beta converting enzyme - related cysteine proteinase III (ice rel-III)
US6110701A (en) 1994-04-08 2000-08-29 Merck Frosst Canada & Co. DNA encoding precursor of interleukin-1β converting enzyme--related cysteine proteinase II (ICErel -II)
DE69519454T2 (de) 1994-07-14 2001-05-03 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo, Okayama Protein, das Interferon-Gamma Herstellung induziert und monoklonaler Antikörper dagegen
TW464656B (en) 1994-11-15 2001-11-21 Hayashibara Biochem Lab Interferon-gamma production inducing polypeptide monoclonal antibody, and agent for interferon-gamma susceptive disease
JP2724987B2 (ja) 1994-11-15 1998-03-09 株式会社林原生物化学研究所 インターフェロン−γの産生を誘導するポリペプチド
US6074050A (en) 1997-12-03 2000-06-13 Hewlett-Packard Company Method and apparatus for venting an ink container
EP0870028A1 (de) 1995-12-29 1998-10-14 Incyte Pharmaceuticals, Inc. Nukleinsäuren, die für interferon gamma-induzierenden faktor kodieren
JPH1080270A (ja) * 1996-07-19 1998-03-31 Hayashibara Biochem Lab Inc ポリペプチドをプロセッシングする酵素
TW515843B (en) * 1996-07-25 2003-01-01 Hayashibara Biochem Lab Process for producing an active polypeptide inducing interferon-γ production
JP4010606B2 (ja) * 1996-07-25 2007-11-21 株式会社林原生物化学研究所 ポリペプチドの製造方法
US6054487A (en) * 1997-03-18 2000-04-25 Basf Aktiengesellschaft Methods and compositions for modulating responsiveness to corticosteroids
AU2149899A (en) * 1998-01-23 1999-08-09 Novo Nordisk A/S Process for making desired polypeptides in yeast

Also Published As

Publication number Publication date
JP5121109B2 (ja) 2013-01-16
AU8044201A (en) 2002-01-02
US7186528B2 (en) 2007-03-06
NO330682B1 (no) 2011-06-06
AR033979A1 (es) 2004-01-21
SI1292697T1 (sl) 2009-12-31
US7442526B2 (en) 2008-10-28
CA2412730C (en) 2011-08-16
JP2004523204A (ja) 2004-08-05
HK1055138A1 (en) 2003-12-24
MXPA02012292A (es) 2003-04-25
CN100390281C (zh) 2008-05-28
HUP0501002A3 (en) 2010-01-28
WO2001098455A2 (en) 2001-12-27
NZ522845A (en) 2005-07-29
NO20026002D0 (no) 2002-12-13
AU2001280442B2 (en) 2005-10-27
CZ20024085A3 (cs) 2003-05-14
IL153422A0 (en) 2003-07-06
BR0111692A (pt) 2005-08-30
WO2001098455A3 (en) 2002-08-08
PL366134A1 (en) 2005-01-24
CA2412730A1 (en) 2001-12-27
ES2329875T3 (es) 2009-12-02
HUP0501002A2 (en) 2006-01-30
EP1292697A2 (de) 2003-03-19
DE60139316D1 (de) 2009-09-03
DK1292697T3 (da) 2009-11-16
EP1292697B1 (de) 2009-07-22
MY136526A (en) 2008-10-31
PL208592B1 (pl) 2011-05-31
PT1292697E (pt) 2009-10-28
EP1292697A4 (de) 2005-08-10
KR20030022144A (ko) 2003-03-15
IL153422A (en) 2011-03-31
US20030143198A1 (en) 2003-07-31
US20060177422A1 (en) 2006-08-10
CN1436246A (zh) 2003-08-13
NO20026002L (no) 2003-02-12

Similar Documents

Publication Publication Date Title
ATA10622000A (de) Verfahren zur herstellung eines haarstreifens
DE60106891D1 (de) Verfahren zur herstellung eines titansilicalitformkörpers
DE60132994D1 (de) Verfahren zur herstellung eines leistungs-mosfets
DE60201421D1 (de) Verfahren zur herstellung eines wachsartigen raffinats
DE60142483D1 (de) Verfahren zur herstellung eines drucksensors
DE60212699D1 (de) Verfahren zur herstellung eines verbundes
ATE300520T1 (de) Verfahren zur herstellung amlodipinmaleat
DE50010576D1 (de) Verfahren zur herstellung eines knochenimplantats
DE60114582D1 (de) Verfahren zur herstellung eines flexiblen polyurethanschaums
DE60224265D1 (de) Verfahren zur herstellung eines mit flanschen versehenen formteils
DE60125114D1 (de) Verfahren zur Herstellung eines Oxid-Supraleiters
DE60231787D1 (de) Verfahren zur herstellung eines aktuators
DE50302301D1 (de) Verfahren zur herstellung eines formteiles
DE60114633D1 (de) Verfahren zur herstellung eines polyurethanmaterials
ATE414058T1 (de) Verfahren zur herstellung eines sulfinyl- acetamids
DE50001155D1 (de) Verfahren zur Herstellung eines Stutzens
ATE437234T1 (de) Verfahren zur herstellung eines physiologisch aktiven il-18 polypeptids
ATE466016T1 (de) Verfahren for zur herstellung eines 14- hydroxynormorphinon-derivats
DE60239489D1 (de) Verfahren zur herstellung eines brennstoffzellenseparators
DE50212805D1 (de) Verfahren zur Herstellung eines Querträgers
DE50010647D1 (de) Verfahren zur herstellung eines feldemissions-displays
DE60105642D1 (de) Verfahren zur herstellung eines doppelkammerbeutels
DE50016026D1 (de) Verfahren zur herstellung eines weichmagnetischen
DE60229198D1 (de) Verfahren zur Herstellung eines Verbundwerkstoffes
DE50111271D1 (de) Verfahren zur herstellung eines membranmoduls

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1292697

Country of ref document: EP